Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:58 AM ET 8-K
M&A Deal Alpine Income Property Trust, Inc. PINE

Alpine Income Property Trust Signs $117M M&A Deal with institutional owner

Alpine Income Property Trust completed the acquisition of a 13-property industrial portfolio for $117.3 million from an institutional seller. The portfolio totals 1.9 million square feet across 11 states and is 100% leased to nine tenants under absolute triple-net leases. The acquisition was funded using borrowings from the company's revolving credit facility.

Value
$117M
Counterparty
institutional owner
Term
10.2 years
6:50 AM ET 8-K
Loan & Debt Accendra Health Inc ACH

Accendra Health $150M Debt Financing with PNC Bank, National Association

Accendra Health's subsidiaries entered into an amendment to their Receivables Purchase Agreement with PNC Bank, extending the $150 million facility's termination date to October 2029. The amendment also revises account control provisions and reporting obligations while maintaining the existing facility size to ensure liquidity. The program is backed by the company's accounts receivable portfolio through its Accendra Funding and Byram Healthcare units.

Value
$150M
Counterparty
PNC Bank, National Association
Term
through Oct 2029
6:49 AM ET Form 4
Insider Selling Nebius Group N.V. NBIS

Nebius Group Insider John Wilson Boynton IV Sells $57.6K of Stock

John Wilson Boynton IV sold 333 shares of Nebius Group N.V. at $173.07 a share, worth $57.6K in total on Oct 29, 2026. Shares held after the trade: 403,189 (-0.1%).

Value
$57.6K
Shares
333
Price
$173.07
Holding change
-0.1%
Trade date
Oct 29, 2026
6:48 AM ET 8-K
Clinical Trial Data Atrium Therapeutics, Inc. RNA

Atrium Therapeutics Clinical Trial Data

Atrium Therapeutics announced nonclinical data for its lead therapy ATR 1072 showing reversal of cardiac glycogen accumulation and improvement in hypertrophy in a mouse model of PRKAG2 syndrome. The company plans to present these findings at the American Heart Association Scientific Sessions 2026 and expects initial Phase 1/2 clinical proof-of-concept data in the second half of 2027.

6:46 AM ET 8-K
Loan & Debt Kosmos Energy Ltd. KOS

Kosmos Energy $1.2B Debt Financing

Kosmos Energy amended and restated its commercial debt facility (A&R RBL), extending the final maturity date to April 1, 2033, and reducing the total facility size to $1.2 billion. The agreement includes an option to increase commitments by up to $550 million and establishes a new $200 million minimum liquidity covenant starting in 2027.

Value
$1.2B
Term
through April 2033
6:46 AM ET 10-Q
Financial Results Sinda Ltd. SIND

Sinda Q3 2026 Results: Net Loss of $14.9M, Loss Widens

Sinda Ltd. completed its initial public offering in June 2026, significantly increasing its cash position to $305.6 million and total stockholders' equity to $311.5 million. The company remains in the exploration stage, reporting a net loss of $43.1 million for the first nine months of 2026 as it scales exploration and administrative activities in Mexico.

Key figure
Net loss $14.9M
6:45 AM ET 8-K
Business Update U.S. GoldMining Inc. USGO

U.S. GoldMining Business Update

U.S. GoldMining provided an operational update on infrastructure developments in the West Susitna Mineral District that benefit its Whistler Gold-Copper Project. Key updates include the U.S. Army Corps of Engineers initiating an expedited emergency permitting process for the state-led West Susitna Access Road and a $249 million federal grant awarded to complete the Port MacKenzie rail extension.

6:45 AM ET 8-K
Financial Results Kosmos Energy Ltd. KOS

Kosmos Energy Financial Results

Kosmos Energy reported its third quarter 2026 financial results, generating a net loss of $43 million and adjusted net income of $35 million. The company highlighted a 6% year-over-year increase in net production to 69,200 boepd and a significant reduction in net debt by over $500 million year-to-date. Additionally, the company completed a $1.2 billion reserve-based lending (RBL) facility amendment and extension to April 2033.

“Kosmos continued to make meaningful progress during the third quarter against the four objectives we established at the beginning of the year: increase production, lower costs, reduce debt and advance our quality growth opportunities. Through a combination of strong operational execution, reduced costs, disciplined capital allocation and proactive financing, we continue to strengthen our business.”

Andrew G. Inglis, Chairman and Chief Executive Officer

“Financially, 2026 continues to represent a year of significant progress for Kosmos. Since the beginning of the year, we have materially improved liquidity, reduced debt, extended maturities, lowered leverage and strengthened the overall credit profile of the company. With the RBL re-financing complete, we have further increased our financial resilience and will now look to address our 2028 bond maturities.”

Andrew G. Inglis, Chairman and Chief Executive Officer
6:39 AM ET Form 4
Insider Buying Steakholder Foods Ltd. STKH

Steakholder Foods CEO Arik Kaufman Buys $38.2K of Stock

Arik Kaufman, CEO, bought 96,826 shares of Steakholder Foods Ltd. at $0.3847 to $0.4 a share (average $0.3942) in 2 transactions, worth $38.2K in total between Oct 29, 2026 and Oct 30, 2026. Shares held after the trade: 112,623 (+114.0%).

Value
$38.2K
Shares
96,826
Average price
$0.3942
Role
CEO
Holding change
+114.0%
Trade date
Oct 29, 2026 to Oct 30, 2026
6:38 AM ET 8-K
Stock Buyback News Corp NWSA

News Stock Buyback Update

News Corp provided a daily update on its existing $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The filing discloses ongoing buy-back transactions for the company's Nasdaq-listed Class A and Class B common stock. No ASX-listed CDIs are being repurchased under this specific program.

6:31 AM ET 8-K
Financial Results Idexx Laboratories Inc IDXX

Idexx Laboratories Financial Results

IDEXX Laboratories reported third quarter 2026 revenue of $1.21 billion, up 10% year-over-year, driven by strong growth in its Companion Animal Group. The company delivered EPS of $4.01 and raised its full-year 2026 revenue and EPS guidance based on strong recurring diagnostics performance.

Term
Q3 2026

“IDEXX delivered exceptional third quarter results, reflecting strong commercial execution and momentum from our innovation-driven growth strategy. Innovations like IDEXX inVue Dx with FNA, and IDEXX Cancer Dx becoming a multi-cancer panel, are helping practices detect disease earlier and work more efficiently.”

Mike Erickson, President and Chief Executive Officer
6:30 AM ET 8-K
Investor Presentation Ferrellgas Partners Finance Corp

Ferrellgas Partners Finance Investor Presentation

Ferrellgas Partners, L.P. has furnished a formal investor presentation dated November 2026 for use in future meetings with current and potential investors and analysts. The presentation provides an overview of the company's business operations and strategic outlook.

6:30 AM ET 8-K
M&A Deal Lazard, Inc. LAZ

Lazard Signs $742M M&A Deal with Campbell Lutyens Holdings Limited

Lazard completed its acquisition of Campbell Lutyens, launching a new global private capital advisory business called Lazard CL. The total consideration includes approximately $448.8 million in initial equity (9.65 million shares at $46.50), $93.2 million in initial cash, $115 million in deferred consideration, and up to $85 million in contingent earn-outs.

Value
$742M
Counterparty
Campbell Lutyens Holdings Limited

“We are thrilled to launch our third global business, Lazard CL. By pairing leading global positions in primary fundraising and secondary advisory with our world-class M&A, capital markets, and restructuring expertise, we are deepening the connectivity between our advisory businesses and strengthening our reach across both the largest strategic transactions and private capital activity.”

Peter Orszag, CEO and Chairman of Lazard
6:23 AM ET 10-Q
Financial Results Cna Financial Corp CNA

Cna Financial Q3 2026 Results: Net Income $196M, Down 51.4% YoY

CNA Financial reported net income of $196 million for the third quarter of 2026, a decrease from $403 million in the prior year period, primarily driven by higher insurance claims and policyholders’ benefits. Total revenues remained stable at $3.82 billion, while the company experienced a significant total comprehensive loss of $837 million due to net unrealized losses on investments.

Key figure
Net income $196M · -51.4% YoY
6:21 AM ET 8-K
Leadership Change Ur-Energy Inc URG

Ur-Energy Leadership Change

Roger L. Smith, CFO and Chief Administrative Officer of Ur-Energy, will retire effective December 1, 2026, after nearly 20 years with the company. Jade Walle, the current VP of Finance and a former PwC audit partner, has been appointed to succeed him as CFO. The company also announced the elimination of the Chief Administrative Officer role, re-allocating those duties among senior management.

6:20 AM ET 8-K
Business Update Biolargo, Inc. BLGO

Biolargo Business Update

BioLargo's subsidiary, Clyra Medical Technologies, provided a commercial update following the SAWC Fall 2026 conference, noting that its ViaCLYR wound irrigation solution is currently undergoing clinical evaluations and approval processes with several U.S. healthcare systems. The company has established a distribution network covering approximately 85% of the U.S. market through partners like Advanced Solution and Spartan Medical.

6:18 AM ET Form 4
Insider Buying Agora, Inc. API

Agora CEO Bin Zhao Buys $81.7K of Stock

Bin Zhao, CEO, bought 18,524 shares of Agora, Inc. at $4.38 to $4.45 a share (average $4.41) in 2 transactions, worth $81.7K in total between Oct 29, 2026 and Oct 30, 2026. Shares held after the trade: 2,253,406 (+0.4%).

Value
$81.7K
Shares
18,524
Average price
$4.41
Role
CEO
Holding change
+0.4%
Trade date
Oct 29, 2026 to Oct 30, 2026
6:14 AM ET 10-Q
Financial Results Mineralrite Corp RITE

Mineralrite Q3 2026 Results: Net Income $359K, Up 1358.3% YoY

MineralRite Corp reported a net income of $4,804 for the nine months ended September 30, 2026, a significant improvement from a net loss of $125,548 in the prior year period. However, the company recorded a massive net loss attributable to common shareholders of $8,743,313 due to a non-cash accounting adjustment related to the repurchase of Series NMC Preferred Stock.

Key figure
Net income $359K · +1358.3% YoY
6:11 AM ET 8-K
Financial Results Cna Financial Corp CNA

Cna Financial Financial Results

CNA Financial reported third quarter 2026 net income of $196 million ($0.72 per share), down from $403 million in the prior year quarter. The results were impacted by higher catastrophe losses and a $137 million after-tax charge related to annual long-term care reserve assumption updates, though P&C segments still generated 3% net written premium growth.

Term
Q3 2026
6:11 AM ET 8-K
Capital Raise Bhav Acquisition Corp II BHAI

Bhav Acquisition Corp II Capital Raise of $100M

BHAV Acquisition Corp II (SPAC) consummated its initial public offering (IPO) of 10,000,000 units at $10.00 per unit, generating gross proceeds of $100 million. Each unit consists of one Class A ordinary share and one right to acquire one-fourth of a share upon completion of a business combination. The company granted underwriters a 45-day option to purchase up to an additional 1.5 million units to cover over-allotments.

Value
$100M
Counterparty
Maxim Group LLC
6:08 AM ET 8-K
Capital Raise Regen BioPharma Inc RGBP

Regen BioPharma Capital Raise

Regen Biopharma entered into a $10 million equity line of credit with Coventry Enterprises, allowing the company to sell shares of common stock at a 20% discount to market prices over a 36-month term. Additionally, the company issued a $125,000 10% unsecured promissory note to Coventry, using a portion of the proceeds to satisfy $71,557 in existing convertible debt.

Counterparty
Coventry Enterprises, LLC
Term
36 months
6:08 AM ET 10-Q
Financial Results Ftai Aviation Ltd. FTAI

Ftai Aviation Q3 2026 Results: Net Income $151M, Up 27.9% YoY

FTAI Aviation Ltd. reported a significant increase in total revenues to $2.76 billion for the nine months ended September 30, 2026, compared to $1.85 billion in the prior year, driven primarily by growth in aerospace products and MRE contract revenue. Net income for the same period rose to $413.6 million, while the company maintained a strong cash position of $385.6 million despite heavy investment in inventory.

Key figure
Net income $151M · +27.9% YoY
6:06 AM ET 8-K
Executive Compensation Advantage Solutions Inc. ADV

Advantage Solutions Executive Compensation

Advantage Solutions entered into amended and restated employment agreements with its CEO David Peacock, CFO Christopher Growe, and COOs Jeffrey Harsh and Michael Taylor. The amendments primarily enhance severance benefits and equity acceleration terms in the event of a qualifying termination following a change in control. Key updates include lump-sum bonus payments, extended COBRA coverage, and 100% accelerated vesting of time-based equity awards.

6:06 AM ET Form 4
Insider Selling Sea Ltd SE

Sea CCO and GC Yanjun Wang Sells $108K of Stock

Yanjun Wang, CCO and GC, sold 1,425 shares of Sea Ltd at $74.52 to $77.12 a share (average $75.48) in 3 transactions, worth $108K in total between Oct 29, 2026 and Oct 30, 2026. Shares held after the trade: 69,647 (-1.0%).

Value
$108K
Shares
1,425
Average price
$75.48
Role
CCO and GC
Holding change
-1.0%
Trade date
Oct 29, 2026 to Oct 30, 2026
6:06 AM ET 8-K
Financial Results Loews Corp L

Loews Financial Results

Loews Corporation reported Q3 2026 net income of $306 million, or $1.50 per share, down from $504 million in the prior year period. The decrease was primarily driven by a $125 million after-tax charge at CNA Financial related to long-term care reserve updates and higher catastrophe losses, partially offset by improved performance at Loews Hotels.

Term
Q3 2026
6:06 AM ET 8-K
M&A Deal Dorchester Minerals, L.P. DMLP

Dorchester Minerals M&A Deal with Hillside Exploration Assets, LLC

Dorchester Minerals, L.P. completed the acquisition of mineral and royalty interests covering approximately 4,300 net royalty acres in the Williston Basin, North Dakota. The transaction was structured as a non-taxable contribution and exchange where the Partnership issued 1,250,000 common units to Hillside Exploration Assets, LLC in exchange for the properties.

Counterparty
Hillside Exploration Assets, LLC
6:06 AM ET 8-K
Shareholder Meeting Deere & Co DE

Deere & Shareholder Meeting

Deere & Company has increased its board size from ten to eleven and appointed Julie Boland, former U.S. CEO of Ernst & Young (EY), as an independent director. Ms. Boland will serve on the Compensation and Finance Committees and receive standard non-employee director compensation, including an initial grant of 92 Restricted Stock Units.

6:06 AM ET 8-K
Business Update Artificial Intelligence Technology Solutions Inc. AITX

Artificial Intelligence Technology Solutions Business Update

Artificial Intelligence Technology Solutions (AITX) launched a marketing campaign for its 'SARA' agentic AI security platform, featuring a simulated job interview with CEO Steve Reinharz. The campaign aims to promote the AI's capabilities in incident management and escalation to security services and remote monitoring providers.

6:05 AM ET 10-Q
Financial Results Rithm Capital Corp. RITM

Rithm Capital Q3 2026 Results: Net Income $253M, Up 14.3% YoY

Rithm Capital Corp. reported net income attributable to common stockholders of $217.1 million for the quarter ended September 30, 2026, up from $193.7 million in the prior year period. Total assets grew to $56.7 billion, driven by increases in mortgage servicing rights and investments within consolidated entities, while the company maintained a steady quarterly dividend of $0.25 per common share.

Key figure
Net income $253M · +14.3% YoY
6:04 AM ET 10-Q
Financial Results Nextpower Inc. NXT

Nextpower Q2 2026 Results: Net Income $165M, Up 12.7% YoY

Nextpower Inc. reported revenue of $1.11 billion for the quarter ended October 2, 2026, representing a 22.5% increase year-over-year. Net income grew to $165.5 million, while the company significantly increased its R&D investment and executed $162.1 million in common stock repurchases during the period.

Key figure
Net income $165M · +12.7% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.